RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Charles J Casamento sold $102K of Relmada Therapeutics, Inc.
Sold$101,618
$33.87Price
3,000Shares
−16%Stake
What RLMD did after the filing
- The stock from Tue, Mar 2 close, $33.66
- +9.9%
- S&P 500, same days
- +6.8%
Measured over 30 trading days, to the Apr 14 close.
Traded Mon, Mar 1. Filed Tue, Mar 2, 11:08 AM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.